Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989

Journal of Clinical Microbiology

Volumn 44, Issue 3, 2006, Pages 861-871

  Norheim, Gunnstein ^a   Rosenqvist, Einar ^a   Aseffa, Abraham ^b   Yassin, Mohammed Ahmed ^c,d   Mengistu, Getahun ^e,f   Kassu, Afework ^e   Fikremariam, Dereje ^g   Tamire, Wegene ^g   Høiby, E Arne ^a   Alebel, Tsegaye ^h   Berhanu, Degu ^b   Merid, Yarid ^d   Harboe, Morten ^b,i   Caugant, Dominique A ^a,i  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d Southern Nations Nationalities and Peoples' Region Health Bureau ^*  (Ethiopia)

^e UNIVERSITY OF GONDAR   (Ethiopia)

^f ADDIS ABABA UNIVERSITY   (Ethiopia)

^g Sidamo Regional Hospital   (Ethiopia)

^h North Gondar Zone Public Health Emergency Management   (Ethiopia)

ⁱ UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; LIPOOLIGOSACCHARIDE; OPA PROTEIN; SULFONAMIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CEREBROSPINAL FLUID CULTURE; CHILD; EPIDEMIC; ETHIOPIA; FEMALE; FETA GENE; HUMAN; INFANT; LGT GENE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPA GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TBPB GENE;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DNA, BACTERIAL; ETHIOPIA; FEMALE; GENES, BACTERIAL; GENOTYPE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS, SEROGROUP A; PHENOTYPE; SEROTYPING; TIME FACTORS;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

EID: 33644932279     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.3.861-871.2006     Document Type: Article

References (57)

1. Achtman, M., B. Kusecek, G. Morelli, K. Rickmann, J. F. Wang, B. Crowe, R. A. Wall, M. Hassan-King, P. S. Moore, and W. Zollinger. 1992. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J. Infect. Dis. 165:53-68.
2. Achtman, M., A. van der Ende, P. Zhu, I. S. Koroleva, B. Kusecek, G. Morelli, I. G. Schuurman, N. Brieske, K. Zurth, N. N. Kostyukova, and A. E. Platonov. 2001. Molecular epidemiology of serogroup A meningitis in Moscow, 1969 to 1997. Emerg. Infect. Dis. 7:420-427.
3. Ajello, G. W., J. C. Feeley, P. S. Hayes, A. L. Reingold, G. Bolan, C. V. Broome, and C. J. Phillips. 1984. Trans-Isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J. Clin. Microbiol. 20:55-58.
4. Bernardini, G., G. Renzone, M. Comanducci, R. Mini, S. Arena, C. D'Ambrosio, S. Bambini, L. Trabalzini, G. Grandi, P. Martelli, M. Achtman, A. Scaloni, G. Ratti, and A. Santucci. 2004. Proteome analysis of Neisseria meningitidis serogroup A. Proteomics 4:2893-2926.
5. Berrington, A. W., Y. C. Tan, Y. Srikhanta, B. Kuipers, P. van der Ley, I. R. Peak, and M. P. Jennings. 2002. Phase variation in meningococcal lipooligosaccharide biosynthesis genes. FEMS Immunol. Med. Microbiol. 34:267-275.
6. Campagne, G., A. Schuchat, S. Djibo, A. Ousseini, L. Cisse, and J. P. Chippaux. 1999. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull. W. H. O. 77:499-508.
7. Castellani, A. 1939. La meningite cerebro-spinale endemique en Afrique orientale Italienne. Bull. Off. Int. Hyg. Publ. 31:455-456.
8. Caugant, D. A. 1998. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 106:505-525.
9. Caugant, D. A., E. A. Høiby, L. O. Frøholm, and P. Brandtzaeg. 1996. Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial. Scand. J. Infect. Dis. 28:149-153.
10. CLSI. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement [M100-S15]. Clinical and Laboratory Standards Institute, Wayne, Pa.
11. Comanducci, M., S. Bambini, B. Brunelli, J. Adu-Bobie, B. Arico, B. Capecchi, M. M. Giuliani, V. Masignani, L. Santini, S. Savino, D. M. Granoff, D. A. Caugant, M. Pizza, R. Rappuoli, and M. Mora. 2002. NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195:1445-1454.
12. Crowe, B. A., R. A. Wall, B. Kusecek, B. Neumann, T. Olyhoek, H. Abdillahi, M. Hassan-King, B. M. Greenwood, J. T. Poolman, and M. Achtman. 1989. Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa. J. Infect. Dis. 159:686-700.
13. Frasch, C. E., and L. F. Mocca. 1978. Heat-modifiable outer membrane proteins of Neisseria meningitidis and their organization within the membrane. J. Bacteriol. 136:1127-1134.
14. Gagneux, S., A. Hodgson, I. Ehrhard, G. Morelli, B. Genton, T. Smith, M. Tanner, F. Binka, M. Achtman, and G. Pluschke. 2000. Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana. Trop. Med. Int. Health 5:280-287.
15. Gedlu, E., and S. I. Rahlenbeck. 1995. Pyogenic meningitis in children in north-western Ethiopia. Ann. Trop. Paediatr. 15:243-247.
16. Gotschlich, E. C. 1994. Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide. J. Exp. Med. 180:2181-2190.
17. Greenwood, B. M., A. K. Bradley, A. W. Smith, and R. A. Wall. 1987. Mortality from meningococcal disease during an epidemic in The Gambia, West Africa. Trans. R. Soc. Trop. Med. Hyg. 81:536-538.
18. Habte-Gabr, E., E. Tekle, and M. Mamo. 1984. Meningococcal meningitis in Ethiopia 1974-1983 and strategies of control. Ethiop. J. Health Dev. 1:47-63.
19. Haimanot, R. T., D. A. Caugant, D. Fekadu, G. Bjune, B. Belete, L. O. Frøholm, E. A. Høiby, E. Rosenqvist, R. K. Selander, and B. Bjorvatn. 1990. Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89. Scand. J. Infect. Dis. 22:171-174.
20. Hughes, J. H., D. J. Biedenbach, M. E. Erwin, and R. N. Jones. 1993. Etest as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates. J. Clin. Microbiol. 31:3255-3259.
21. Issa, M., P. Mölling, A. Bäckman, M. Unemo, N. Sulaiman, and P. Olcén. 2003. PCR of cerebrospinal fluid for diagnosis of bacterial meningitis during meningococcal epidemics; an example from Sudan. Scand. J. Infect. Dis. 35:719-723.
22. Jacobsson, S., M. Issa, M. Unemo, A. Bäckman, P. Mölling, N. Sulaiman, and P. Olcén. 2003. Molecular characterisation of group A Neisseria meningitidis isolated in Sudan 1985-2001. APMIS 111:1060-1066.
23. Jodar, L., F. M. LaForce, C. Ceccarini, T. Aguado, and D. M. Granoff. 2003. Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries. Lancet 361:1902-1904.
24. Kim, J. J., N. J. Phillips, B. W. Gibson, J. M. Griffiss, and R. Yamasaki. 1994. Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes. Infect. Immun. 62:1566-1575.
25. Kristos, T. G., and L. Muhe. 1993. Epidemic meningococcal meningitis in children. A retrospective analysis of cases admitted to ESCH (1988). Ethiop. Med. J. 31:9-14.
26. Lapeyssonnie, L. 1963. Cerebrospinal meningitis in Africa. Bull. W. H. O. 28:3-114.
27. Legrain, M., B. Rokbi, D. Villeval, and E. Jacobs. 1998. Characterization of genetic exchanges between various highly divergent tbpBs, having occurred in Neisseria meningitidis. Gene 208:51-59.
28. Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods 126:109-117.
29. Linz, B., M. Schenker, P. Zhu, and M. Achtman. 2000. Frequent interspecific genetic exchange between commensal neisseriae and Neisseria meningitidis. Mol. Microbiol. 36:1049-1058.
30. Mackinnon, F. G., A. D. Cox, J. S. Plested, C. M. Tang, K. Makepeace, P. A. Coull, J. C. Wright, R. Chalmers, D. W. Hood, J. C. Richards, and E. R. Moxon. 2002. Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis. Mol. Microbiol. 43:931-943.
31. Maiden, M. C., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95:3140-3145.
32. Martin, P., K. Makepeace, S. A. Hill, D. W. Hood, and E. R. Moxon. 2005. Microsatellite instability regulates transcription factor binding and gene expression. Proc. Natl. Acad. Sci. USA 102:3800-3804.
33. Mengistu, G., K. Mitiku, and W. Teferi. 2003. Analysis and reporting of meningococcal meningitis epidemic in north Gondar 2001-2002. Ethiop. Med. J. 41:319-331.
34. Nicolas, P., L. Decousset, V. Riglet, P. Castelli, R. Stor, and G. Blanchet. 2001. Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerg. Infect. Dis. 7:849-854.
35. Nicolas, P., G. Norheim, E. Garnotel, S. Djibo, and D. A. Caugant. 2005. Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J. Clin. Microbiol. 43:5129-5135.
36. Njanpop-Lafourcade, B. M., I. Parent du Chatelet, O. Sanou, J. M. Alonso, and M. K. Taha. 2005. The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso. Microbes Infect. 7:645-649.
37. Norheim, G., A. Aase, D. A. Caugant, E. A. Høiby, E. Fritzsønn, T. Tangen, P. Kristiansen, U. Heggelund, and E. Rosenqvist. 2005. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Vaccine 23:3762-3774.
38. Parent du Chatelet, I., Y. Traore, B. D. Gessner, A. Antignac, B. Naccro, B. M. Njanpop-Lafourcade, M. S. Ouedraogo, S. R. Tiendrebeogo, E. Varon, and M. K. Taha. 2005. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin. Infect. Dis. 40:17-25.
39. Peltola, H. 2001. Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin. Infect. Dis. 32:64-75.
40. Pettersson, A., A. Maas, D. van Wassenaar, P. van der Ley, and J. Tommassen. 1995. Molecular characterization of FrpB, the 70-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis. Infect. Immun. 63:4181-4184.
41. Popovic, T., G. W. Ajello, R. Racklam, D. A. Caugant, P. Nicolas, B. A. Perkins, N. E. Rosenstein, and E. Tikhomirov. 1999. Laboratory manual for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumonias, and Haemophilia influenzae. Document no. WHO/CDS/CSR/EDC/99.7. World Health Organization, Geneva, Switzerland.
42. Salih, M. A., D. Danielsson, A. Bäckman, D. A. Caugant, M. Achtman, and P. Olcén. 1990. Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J. Clin. Microbiol. 28:1711-1719.
43. Shultz, T. R., J. W. Tapsall, P. A. White, C. S. Ryan, D. Lyras, J. I. Rood, E. Binotto, and C. J. Richardson. 2003. Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia. J. Antimicrob. Chemother. 52:856-859.
44. Suker, J., I. M. Feavers, M. Achtman, G. Morelli, J. F. Wang, and M. C. Maiden. 1994. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol. Microbiol. 12:253-265.
45. Taha, M. K. 2000. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J. Clin. Microbiol. 38:855-857.
46. Tedla, T. 1993. Meningococcal meningitis, p. 285-293. In H. Kloos and A. Zein (ed.), Health and disease in Ethiopia. Westview Press, Boulder, Colo.
47. Thompson, E. A., I. M. Feavers, and M. C. Maiden. 2003. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149:1849-1858.
48. Tondella, M. L., N. E. Rosenstein, L. W. Mayer, F. C. Tenover, S. A. Stocker, M. W. Reeves, and T. Popovic. 2001. Lack of evidence for chloramphenicol resistance in Neisseria meningitidis, Africa. Emerg. Infect. Dis. 7:163-164.
49. Urwin, R., J. E. Russell, E. A. Thompson, E. C. Holmes, I. M. Feavers, and M. C. Maiden. 2004. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect. Immun. 72:5955-5962.
50. van der Ley, P., J. van der Biezen, R. Sutmuller, P. Hoogerhout, and J. T. Poolman. 1996. Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae. Microbiology 142:3269-3274.
51. Wedege, E. 2001. Immunoblot analysis of sera from patients and vaccinees, p. 275-288. In A. J. Pollard and M. C. Maiden (ed.), Methods in molecular medicine: meningococcal vaccines. Methods and protocols. Humana Press, Totowa, N.J.
52. Wedege, E., E. A. Høiby, E. Rosenqvist, and L. O. Frøholm. 1990. Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J. Med. Microbiol. 31:195-201.
53. World Health Organization. 1998. Control of epidemic meningococcal disease. WHO practical guidelines. Document no. WHO/EMC/BAC/98.3. World Health Organization, Geneva, Switzerland.
54. World Health Organization. 2002. Meningococcal disease, serogroup W135, Burkina Faso: preliminary report 2002. Wkly. Epidemiol. Rec. 77:152-155.
55. Wright, L. J., and J. J. Plorde. 1970. Group-A sulfadiazine-resistant Neisseria meningitidis in Ethiopia. Lancet ii:1033.
56. Zhu, P., M. J. Klutch, M. C. Bash, R. S. Tsang, L. K. Ng, and C. M. Tsai. 2002. Genetic diversity of three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species. Microbiology 148:1833-1844.
57. Zhu, P., A. van der Ende, D. Falush, N. Brieske, G. Morelli, B. Linz, T. Popovic, I. G. Schuurman, R. A. Adegbola, K. Zurth, S. Gagneux, A. E. Platonov, J. Y. Riou, D. A. Caugant, P. Nicolas, and M. Achlman. 2001. Fit genotypes and escape variants of subgroup III Neisseria meningitidis during three pandemics of epidemic meningitis. Proc. Natl. Acad. Sci. USA 98:5234-5239.